Nathaniel Rosal

Nathaniel Rosal

Auto-generated profile, based on publicly available information

Nathaniel Rosal

Abington Memorial Hospital-Jefferson Health, Abington, PA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Investigative Medicine High Impact Case Reports
Verified
Journal Article
Open access
NRNathaniel R. Rosal
Nathaniel R. Rosal
FTFranklin L. Thelmo
Franklin L. Thelmo
STStephanie Tzarnas
Stephanie Tzarnas
LDLauren DiCalvo
Lauren DiCalvo
STShafaq Tariq
Shafaq Tariq
CGCraig Grossman
Craig Grossman
Wooden chest syndrome (WCS) describes a finding of fentanyl-induced skeletal muscle rigidity causing ventilatory failure. Known primarily to anesthesiology, pulmonary, and critical care fields, WCS is a rare complication that may affect patients of all ages if exposed to intravenous fentanyl, characterized by a patient’s inability to properly ventilate. Given the rise of synthetic opioid deaths across the United States in the past decade, an understanding of all of fentanyl’s effects on the body is necessary. In this article, we present a case of WCS in a patient with acute respiratory distress syndrome in a 61-year-old female.

1 July 2021 in Journal of Investigative Medicine High Impact Case Reports
Verified
Journal Article
Open access
PDF file
NRNathaniel R. Rosal
Nathaniel R. Rosal
FTFranklin L. Thelmo
Franklin L. Thelmo
STStephanie Tzarnas
Stephanie Tzarnas
LDLauren DiCalvo
Lauren DiCalvo
STShafaq Tariq
Shafaq Tariq
CGCraig Grossman
Craig Grossman
Wooden chest syndrome (WCS) describes a finding of fentanyl-induced skeletal muscle rigidity causing ventilatory failure. Known primarily to anesthesiology, pulmonary, and critical care fields, WCS is a rare complication that may affect patients of all ages if exposed to intravenous fentanyl, characterized by a patient's inability to properly ventilate. Given the rise of synthetic opioid deaths across the United States in the past decade, an understanding of all of fentanyl's effects on the body is necessary. In this article, we present a case of WCS in a patient with acute respiratory distress syndrome in a 61-year-old female.

5 May 2022 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
HMHamza Zahid Ullah Muhammadzai
Hamza Zahid Ullah Muhammadzai
NRNathaniel Rosal
Nathaniel Rosal
MCMuhammad Arslan Cheema
Muhammad Arslan Cheema
DHDonald Haas
Donald Haas
Background: Coronavirus disease 2019 (COVID-19) is a manifestation of severe acute respiratory syndrome coronavirus 2, which results in many different complications including left ventricular (LV) thrombi. Case summary: We present a 30-year-old female presenting with chest pain and shortness of breath. Patient had an extensive history including heart failure with an ejection fraction 15–20% and COVID-19 2 months ago. Echocardiogram revealed a 3.3 cm × 1.7 cm LV thrombus which was not present 4 months ago before her diagnosis of COVID-19. The LV thrombus embolized resulting in an embolus extending from the distal infrarenal abdominal aorta to the common iliac arteries bilaterally. Repeat COVID pre-procedure was positive. She underwent bilateral femoral artery cutdown, bilateral iliac artery embolectomy, superficial femoral artery embolectomy, and bilateral lower extremity fasciotomy. An extensive workup for the aetiology of the LV thrombus turned out to be negative and COVID-19 was deemed to be the aetiology of the thrombus. The patient was bridged from apixaban to warfarin and was successfully discharged within a few weeks. Discussion: Hypercoagulability is a known complication of COVID-19 causing thrombi in various parts of the body including the LV. Early recognition with echocardiography, especially in patients with heart failure, and prompt treatment is key to avoid further complications such as embolization.

29 December 2020 in Cureus
Verified
Journal Article
Open access
PDF file
MKMuhammad Atique Alam Khan
Muhammad Atique Alam Khan
NRNathaniel Rosal
Nathaniel Rosal
IIIqra Iqbal
Iqra Iqbal
AMArtem Minalyan
Artem Minalyan
The coronavirus disease 2019 (COVID-19) epidemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China, then declared to be a pandemic associated with substantial morbidity and mortality. It has shown to exhibit a vast array of symptoms, among which fever, shortness of breath, and cough are the most commonly reported. Lymphadenopathy and tonsillar enlargement is a less common finding reported with this infection. This case describes a patient with tonsillar inflammation which was complicated by peritonsillar phlegmon, with negative throat culture and positive COVID-19 test, suggesting a COVID-19-related etiology of the disease. After the literature search, to the best of our knowledge, this is the first reported case of COVID-related peritonsillar inflammation and phlegmon formation.

3 May 2021
Verified
Conference Paper
Open access
NRN. Rosal
N. Rosal
LDL. DiCalvo
L. DiCalvo
STS. Tariq
S. Tariq
CGC. Grossman
C. Grossman